Matches in Nanopublications for { ?s ?p "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 19 of
19
with 100 items per page.
- NP624388.RAbYTAa8Hx0a6FR6LPY9q7QoG6eCHLujVpU89ZPnRZ2Oc130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624388.RAbYTAa8Hx0a6FR6LPY9q7QoG6eCHLujVpU89ZPnRZ2Oc130_provenance.
- NP646451.RAbse4bdnhbQdhLBJUF16Or0FjHSaeqTVhBBuya8_MESM130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646451.RAbse4bdnhbQdhLBJUF16Or0FjHSaeqTVhBBuya8_MESM130_provenance.
- NP1177342.RAS_uoL6-2ncYMadKK022UnaoAOSesZfOCPX3Vcbq8NDs130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177342.RAS_uoL6-2ncYMadKK022UnaoAOSesZfOCPX3Vcbq8NDs130_provenance.
- NP621862.RAveKmnjqJNHUUiwjG8eLvVNiOQg8SHTM8aMFVFGSw6Uc130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621862.RAveKmnjqJNHUUiwjG8eLvVNiOQg8SHTM8aMFVFGSw6Uc130_provenance.
- NP664619.RAqNjF-rNYfgzwudngYRzmvyS3TIUk8gh-3hbRm8D3-Jg130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664619.RAqNjF-rNYfgzwudngYRzmvyS3TIUk8gh-3hbRm8D3-Jg130_provenance.
- NP1177331.RAtSIsEfJVFP6KzRpBR-7a84XCOrTFYlI6hqM2-RBkA_k130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177331.RAtSIsEfJVFP6KzRpBR-7a84XCOrTFYlI6hqM2-RBkA_k130_provenance.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.
- NP232689.RAPfwbHQsm6cdqNaE-D0L9d-RocRJV6v1Kp07-3aYY2og130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232689.RAPfwbHQsm6cdqNaE-D0L9d-RocRJV6v1Kp07-3aYY2og130_provenance.
- NP644609.RAOC1biYZBHlFepSuK24JBlWbcmYOJ0QnkGe64k50E_KE130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644609.RAOC1biYZBHlFepSuK24JBlWbcmYOJ0QnkGe64k50E_KE130_provenance.
- NP376935.RA1zba4RjxUDe-9H9iOzPleXeBJD_EuUh4c0KicizIhRo130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376935.RA1zba4RjxUDe-9H9iOzPleXeBJD_EuUh4c0KicizIhRo130_provenance.
- NP623073.RA61TYr1UrZ1IZuCP3QrkarH6TpmRvWETsyCjHkUXZMks130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623073.RA61TYr1UrZ1IZuCP3QrkarH6TpmRvWETsyCjHkUXZMks130_provenance.
- NP625528.RA7yOKGEiV8eQWPjbLcoCgdiGTfXAi7aqHKs3opVpuzTg130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625528.RA7yOKGEiV8eQWPjbLcoCgdiGTfXAi7aqHKs3opVpuzTg130_provenance.
- NP1177334.RAJQRjz7-A1-OeAgHH_PYeY4Ven_BdP4Z0s_cqGn_p3qE130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177334.RAJQRjz7-A1-OeAgHH_PYeY4Ven_BdP4Z0s_cqGn_p3qE130_provenance.
- NP1177336.RAFyKoHs5FB2YviI3wGNgszrfwQMSuDj2UnMjC1tw5wWM130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177336.RAFyKoHs5FB2YviI3wGNgszrfwQMSuDj2UnMjC1tw5wWM130_provenance.
- NP1177333.RAwnP45fh_SCaZbetZFOmr2bOVqZ6lHVKw3kHkq_-vXeE130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177333.RAwnP45fh_SCaZbetZFOmr2bOVqZ6lHVKw3kHkq_-vXeE130_provenance.
- NP1177337.RAy0chLZesuvtqYMyaKv8QkDK3yfP6EYnPUygsZEgQ8gg130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177337.RAy0chLZesuvtqYMyaKv8QkDK3yfP6EYnPUygsZEgQ8gg130_provenance.
- NP1177340.RA9GJWa7zOLl7rnLQhYm-PrQeAKzJZQcJdz18ERaqtypk130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177340.RA9GJWa7zOLl7rnLQhYm-PrQeAKzJZQcJdz18ERaqtypk130_provenance.
- NP1177343.RA6VvHZdNTNd2hP4ylNC9ZoCq__fjx13o3okeEKSoc-xg130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177343.RA6VvHZdNTNd2hP4ylNC9ZoCq__fjx13o3okeEKSoc-xg130_provenance.
- NP1177344.RA0_w49pOnoUbGLl_X5crsbn8Ll12E_StQavV3Z6XwsjY130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177344.RA0_w49pOnoUbGLl_X5crsbn8Ll12E_StQavV3Z6XwsjY130_provenance.